Literature DB >> 16174939

Mechanical recanalization for acute ischemic stroke.

Shinichi Nakano1, Shimichiro Wakisaka.   

Abstract

Thrombolysis has become accepted as an effective treatment for acute ischemic stroke. However, two major problems remain: failure of recanalization and hemorrhagic complications. The combined use of mechanical recanalization techniques with thrombolytic agents occasionally may be required to improve recanalization rates and to reduce hemorrhagic complications. Percutaneous transluminal angioplasty (PTA), clot extraction utilizing retrieval devices, and clot fragmentation using energy of ultrasonic or laser vibrations and suction-creating saline jets are possible effective mechanical recanalization strategies, but mainly as a rescue therapy for patients with failed thrombolysis. However, for large artery occlusions, thrombolysis alone often results in failure of recanalization. In such cases, to minimize the total dose of thrombolytic agents and to prevent hemorrhagic complications, mechanical recanalization may be alternatively selected as the first choice of treatment. The safety and effectiveness of PTA for acute middle cerebral artery trunk occlusion has been reported using additional thrombolysis with low doses of thrombolytic agents for distal embolism by crushed fragments. Reduction of total doses of thrombolytic agents may decrease serious hemorrhagic complications, resulting in better clinical outcome.

Entities:  

Mesh:

Year:  2004        PMID: 16174939     DOI: 10.1385/NCC:1:3:379

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  33 in total

1.  Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism.

Authors:  A Furlan; R Higashida; L Wechsler; M Gent; H Rowley; C Kase; M Pessin; A Ahuja; F Callahan; W M Clark; F Silver; F Rivera
Journal:  JAMA       Date:  1999-12-01       Impact factor: 56.272

2.  Direct percutaneous transluminal angioplasty for acute middle cerebral artery occlusion.

Authors:  S Nakano; K Yokogami; H Ohta; T Yano; T Ohnishi
Journal:  AJNR Am J Neuroradiol       Date:  1998-04       Impact factor: 3.825

3.  PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism.

Authors:  G J del Zoppo; R T Higashida; A J Furlan; M S Pessin; H A Rowley; M Gent
Journal:  Stroke       Date:  1998-01       Impact factor: 7.914

4.  Time-threshold curve determined by single photon emission CT in patients with acute middle cerebral artery occlusion.

Authors:  Tsutomu Iseda; Shinichi Nakano; Takao Yano; Yukiko Suzuki; Shinichiro Wakisaka
Journal:  AJNR Am J Neuroradiol       Date:  2002-04       Impact factor: 3.825

5.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

Review 6.  Acute stroke therapy: beyond i.v. tPA.

Authors:  Anthony J Furlan
Journal:  Cleve Clin J Med       Date:  2002-09       Impact factor: 2.321

7.  Angioplasty after intra-arterial thrombolysis for acute occlusion of intracranial arteries.

Authors:  T Ueda; S Sakaki; I Nochide; Y Kumon; K Kohno; S Ohta
Journal:  Stroke       Date:  1998-12       Impact factor: 7.914

8.  Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators.

Authors:  W Hacke; M Kaste; C Fieschi; R von Kummer; A Davalos; D Meier; V Larrue; E Bluhmki; S Davis; G Donnan; D Schneider; E Diez-Tejedor; P Trouillas
Journal:  Lancet       Date:  1998-10-17       Impact factor: 79.321

Review 9.  Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.

Authors:  Ellen C Keeley; Judith A Boura; Cindy L Grines
Journal:  Lancet       Date:  2003-01-04       Impact factor: 79.321

10.  Treatment of basilar artery embolism with a mechanical extraction device: necessity of flow reversal.

Authors:  Thomas E Mayer; Gerhard F Hamann; Hartmut J Brueckmann
Journal:  Stroke       Date:  2002-09       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.